Safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer: Short-term results of a multicenter, phase II study
单位:[1]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[2]Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China临床科室国家中心普外分中心普外五科(综合普外科)首都医科大学附属北京友谊医院[3]Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China[4]Capital Med Univ Hosp, Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[5]Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China首都医科大学附属北京友谊医院[6]Capital Med Univ, Beijing Friendship Hosp, Dept Pathol, Beijing, Peoples R China医技科室病理科病理科首都医科大学附属北京友谊医院[7]Beijng Chaoyang Hosp, Beijing, Peoples R China北京朝阳医院[8]Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, Beijing, Peoples R China首都医科大学宣武医院[9]Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China[10]Tianjin Peoples Hosp, Dept Anorectal, Tianjin, Peoples R China[11]Tianjin Med Univ Canc Inst & Hosp, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc,Dept Colorectal Canc, Key Lab Canc Prevent & Therapy Tianjin, Tianjin, Peoples R China
第一作者单位:[1]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China[2]Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China[3]Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China[4]Capital Med Univ Hosp, Beijing Friendship Hosp, Beijing, Peoples R China[5]Capital Med Univ, Beijing Friendship Hosp, Dept Radiol, Beijing, Peoples R China[6]Capital Med Univ, Beijing Friendship Hosp, Dept Pathol, Beijing, Peoples R China[7]Beijng Chaoyang Hosp, Beijing, Peoples R China[8]Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, Beijing, Peoples R China[9]Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China[10]Tianjin Peoples Hosp, Dept Anorectal, Tianjin, Peoples R China[11]Tianjin Med Univ Canc Inst & Hosp, Tianjins Clin Res Ctr Canc, Natl Clin Res Ctr Canc,Dept Colorectal Canc, Key Lab Canc Prevent & Therapy Tianjin, Tianjin, Peoples R China
推荐引用方式(GB/T 7714):
Yao Hongwei,Yang Zhengyang,Gao Jiale,et al.Safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer: Short-term results of a multicenter, phase II study[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):E15599-E15599.doi:10.1200/JCO.2022.40.16_suppl.e15599.
APA:
Yao, Hongwei,Yang, Zhengyang,Gao, Jiale,Zhang, Xiao,Wu, Guocong...&Zhang, Zhongtao.(2022).Safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer: Short-term results of a multicenter, phase II study.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA:
Yao, Hongwei,et al."Safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer: Short-term results of a multicenter, phase II study".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022):E15599-E15599